KORU Medical Systems, Inc.
KRMDNasdaqCIK 704440HealthcareFiscal year ends Dec 31
Reports and events: 231 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1420:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001161697-26-000200 |
| 2026-08-0520:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001161697-26-000189 |
| 2026-08-0520:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-26-000188 |
| 2026-06-3020:57 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001161697-26-000139 |
| 2026-05-2120:11 ET | 8-K | 5.07 Shareholder vote results | 0001161697-26-000128 |
| 2026-05-0620:04 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001161697-26-000108 |
| 2026-05-0620:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-26-000107 |
| 2026-04-0920:03 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001161697-26-000091 |
| 2026-04-0320:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001161697-26-000086 |
| 2026-03-1601:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-26-000055 |
| 2026-03-1220:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001161697-26-000052 |
| 2026-03-1220:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-26-000051 |
| 2026-02-1321:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001161697-26-000042 |
| 2026-02-1102:08 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001161697-26-000038 |
| 2026-01-1215:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-26-000027 |
| 2025-11-2521:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001161697-25-000426 |
| 2025-11-1221:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001161697-25-000372 |
| 2025-11-1221:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-25-000371 |
| 2025-08-0620:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001161697-25-000217 |
| 2025-08-0620:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-25-000216 |
| 2025-05-1520:56 ET | 8-K | 5.07 Shareholder vote results | 0001161697-25-000173 |
| 2025-05-0720:22 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001161697-25-000169 |
| 2025-05-0720:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-25-000168 |
| 2025-04-0720:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001161697-25-000142 |
| 2025-04-0420:03 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001161697-25-000140 |
| 2025-04-0420:02 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001161697-25-000139 |
| 2025-03-1220:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001161697-25-000103 |
| 2025-03-1220:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-25-000099 |
| 2025-01-2101:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001161697-25-000060 |
| 2025-01-1314:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001161697-25-000050 |
| 2024-11-1321:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001161697-24-000441 |
| 2024-11-1321:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-24-000440 |
| 2024-08-2121:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-24-000365 |
| 2024-08-0720:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-24-000335 |
| 2024-08-0720:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001161697-24-000334 |
| 2024-07-2420:25 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001161697-24-000314 |
| 2024-06-0321:19 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001161697-24-000250 |
| 2024-05-1421:06 ET | 8-K | 5.07 Shareholder vote results | 0001161697-24-000230 |
| 2024-05-0120:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001161697-24-000226 |
| 2024-05-0120:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-24-000225 |
| 2024-04-1120:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-24-000196 |
| 2024-03-2820:30 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001161697-24-000162 |
| 2024-03-1320:19 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001161697-24-000140 |
| 2024-03-1320:18 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001161697-24-000139 |
| 2024-01-0223:20 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-306041 |
| 2023-11-0821:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001161697-23-000568 |
| 2023-11-0821:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-23-000567 |
| 2023-10-0420:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001161697-23-000522 |
| 2023-08-0920:20 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001161697-23-000443 |
| 2023-08-0920:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001161697-23-000441 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.